CWM
ACLS icon

Cranbrook Wealth Management’s Axcelis ACLS Stock Holding History

Cranbrook Wealth Management’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,673
Closed -$280K – 413
2024
Q3 		$280K Hold
2,673
– – 0.06% 97
2024
Q2 		$380K Buy
2,673
+1,226
+85% +$141K 0.09% 86
2024
Q1 		$161K Hold
1,447
– – 0.04% 99
2023
Q4 		$188K Hold
1,447
– – 0.05% 95
2023
Q3 		$236K Hold
1,447
– – 0.07% 82
2023
Q2 		$265K Buy
+1,447
New +$208K 0.07% 83

Other funds holding ACLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Cranbrook Wealth Management's ACLS Position: Q4 2024 in Review

Cranbrook Wealth Management sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 2,673 shares — an estimated $280K sold.

Cranbrook Wealth Management first reported a position in ACLS in Q2 2023 and held it in 6 quarters. The position peaked at $380K in Q2 2024. 324 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

  • Cranbrook Wealth Management reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
  • Cranbrook Wealth Management sold 2,673 Axcelis shares in Q4 2024, an estimated $280K.
  • Cranbrook Wealth Management first reported a position in Axcelis in Q2 2023 and held it in 6 quarters.
  • Cranbrook Wealth Management's Axcelis position peaked at $380K in Q2 2024.
  • 324 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on Cranbrook Wealth Management's 13F filing for Q4 2024, filed 15 Jan 2025.